Giorgio Senaldi
12Patents
7h-index
29Co-inventors
58Inventor score
Filing activity: Aug 16, 2001 → Apr 2, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7285269B2 | Antibodies directed to tumor necrosis factor | Chemistry; Metallurgy | 68 | Expired |
| US7423128B2 | Anti-properdin antibodies, and methods for making and using same | Chemistry; Metallurgy | 55 | Expired |
| US7566772B2 | Antibodies against interleukin-1β | Emerging Cross-Sectional Technologies | 42 | Expired |
| US7585500B2 | Fully human monoclonal antibodies to IL-13 | Chemistry; Metallurgy | 16 | Active |
| US7708993B2 | Polypeptides involved in immune response | Chemistry; Metallurgy | 15 | Expired |
| US7964193B2 | Antibodies against interleukin-1 β | Emerging Cross-Sectional Technologies | 12 | Active |
| US7994302B2 | Fully human monoclonal antibodies to IL-13 | Chemistry; Metallurgy | 8 | Active |
| US7569387B2 | Antibody to TNF receptor-like molecules | Chemistry; Metallurgy | 3 | Active |
| US8101178B2 | Antibodies directed to tumor necrosis factor and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US7153669B2 | Nucleic acids encoding MK61 receptors | Chemistry; Metallurgy | 1 | Expired |
| US8309083B2 | Polypeptides involved in immune response | Chemistry; Metallurgy | 0 | Active |
| US6849260B2 | Methods and compositions for treating IgE-related disease using NNT-1 inhibitors | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.